Locations
Cambridge, MA, USA · Cambridge, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology
Size
11-50 employees
Stage
Series B
founded in
2020
Rome Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, Rome is moving rapidly to leverage this new frontier in biology. To lead this exploration, Rome has assembled a team of world-class leaders across fields including oncology, immunology, virology, and machine learning. Rome was launched in April 2020 and was incubated at GV, in collaboration with Arch Venture Partners and Partners Innovation Fund. Rome is based in Cambridge, Mass. For more information, please visit www.rometx.com.
Something looks off?